Skip to content

Comparison of 68Ga-FAPI-04 with 18F-FDG in abdominal neoplasms

Comparison of 68Ga-FAPI-04 with 18F-FDG in abdominal neoplasms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052378
Enrollment
Unknown
Registered
2021-10-24
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdominal neoplasms

Interventions

Gold Standard:Surgery or needle biopsy
Index test:Alpha-fetoprotein,&#32
carbohydrate&#32
199,&#32

Sponsors

The First Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. There is no age limit, male or female; 2. The research object is clinically suspected or diagnosed tumor patients; 3. Participants who have completed 18F-FDG and 68Ga-FAPI-04 PET/CT scans; 4. There is at least one measurable target lesion according to RECIST1.1; 5. Participants who are able to provide informed consent (signed by the participant, parent or legal representative) and consent in accordance with the guidelines of the Clinical Research Ethics Committee.

Exclusion criteria

Exclusion criteria: 1. Serious abnormality of liver and kidney function; 2. Pregnant women, pregnant women and lactating women; 3. Those who cannot lie flat for half an hour; 4. Suffering from claustrophobia or other mental illness; 5. Treatment has started between PET scans; 6. Other investigators think that it is not suitable to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Standard uptake value max;Standard uptake value mean;

Countries

China

Contacts

Public ContactZhang Zeyu

The First Affiliated Hospital of Naval Medical University

zeyu-zhang@foxmail.com+86 19921602386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026